Your session is about to expire
← Back to Search
Inhalational vs Intravenous Anesthesia for Surgery Patients (TIVA GAS Trial)
TIVA GAS Trial Summary
This trial compares the effects of two types of anesthesia on outcomes for elderly surgery patients. It will look at postoperative delirium, cognitive dysfunction, functional decline, patient-reported outcomes, and more.
TIVA GAS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTIVA GAS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.TIVA GAS Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is entry into this medical trial restricted to adults only?
"This particular medical research study is targeting elderly patients between 75 and 105 years of age. By contrast, there are 68 trials that accommodate individuals below 18 and 753 for those over 65."
Is this trial presently seeking new participants?
"The medical investigation has been listed on the clinicaltrials.gov website since August 14th 2023 and was recently updated on September 6th of the same year, indicating that it is still in need of participants."
How many participants are included in this research endeavor?
"Affirmative. According to the clinicaltrials.gov site, this medical trial has been recruiting participants since August 14th 2023 and is still actively seeking 260 patients from a single location for enrolment."
Has Inhalational Anesthesia been deemed safe by the FDA?
"The efficacy and safety of Inhalational Anesthesia has been widely established, resulting in a score of 3."
What is the objective of this research endeavor?
"This clinical trial will evaluate the effects of intravenous vs. inhalational anesthesia on postoperative neurocognitive disorder and functional decline in older adults undergoing non-cardiac surgery for a duration that spans 3 days postoperatively, along with levels of blood phosphorylated tau 181 (p-tau181) at preoperative baseline as well as postoperative day 1, 3 months and 12 months. Patient-reported outcomes such as anxiety, depression, fatigue, pain interference, physical function sleep disturbance etc., assessed through PROMIS-29+2 Profile v2.1 (PROPr), are also being measured at preoperative"
Would I be eligible to participate in this research experiment?
"To qualify for this medical research, candidates must be of aged between 75 and 105 with some form of neurocognitive disorder. The trial requires 260 participants in total."
Share this study with friends
Copy Link
Messenger